195 related articles for article (PubMed ID: 9123150)
21. Management of acute steroid-resistant rejection after liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lemmens P; Lobeck H; Neuhaus P
World J Surg; 1996 Oct; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
[TBL] [Abstract][Full Text] [Related]
22. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
23. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
Carl S; Dörsam J; Mandelbaum A; Staehler G; Wiesel M
Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
[No Abstract] [Full Text] [Related]
24. Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
Klupp J; Bechstein WO; Pratschke J; Tullius SG; Gebhard A; Lobeck H; Langrehr JM; Neuhaus R; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1443-4. PubMed ID: 9636585
[No Abstract] [Full Text] [Related]
25. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473
[No Abstract] [Full Text] [Related]
26. Does initial graft function influence the outcome after liver transplantation?
Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
[No Abstract] [Full Text] [Related]
27. FK506 rescue therapy in lung transplantation.
Wiebe K; Harringer W; Franke U; Strüber M; Krug N; Korff F; Wahlers T; Cremer J; Haverich A
Transplant Proc; 1998 Jun; 30(4):1508-9. PubMed ID: 9636613
[No Abstract] [Full Text] [Related]
28. Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy.
Kaufman DB; Leventhal JR; Stuart J; Parker M; Abecassis M; Fryer JP; Stuart FP
Transplant Proc; 1999; 31(1-2):615-6. PubMed ID: 10083261
[No Abstract] [Full Text] [Related]
29. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
Meijer RT; Keur I; Surachno S; ten Berge IJ; Schellekens PT
Transplant Proc; 2001 May; 33(3):2196-7. PubMed ID: 11377501
[No Abstract] [Full Text] [Related]
30. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
[No Abstract] [Full Text] [Related]
31. Acute pancreatitis complicating OKT3 administration for resistant cardiac rejection.
Scheinin S; Radovancevic B; Frazier OH
Transplant Proc; 1993 Jun; 25(3):2368-9. PubMed ID: 8516933
[No Abstract] [Full Text] [Related]
32. Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.
Kliem V; Schaumann D; Ehlerding G; Eberhard OK; Lufft V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
Transplant Proc; 1997 Nov; 29(7):2955-7. PubMed ID: 9365627
[No Abstract] [Full Text] [Related]
33. ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
Kumar MS; Cahill K; Kumar AM; Panigrahi D; Seirka D; Singleton R; al-Abdullah IH; Laskow DA
Transplant Proc; 1998 Jun; 30(4):1351-2. PubMed ID: 9636549
[No Abstract] [Full Text] [Related]
34. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
35. Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
Kliem V; Petersen R; Ehlerding G; Schaumann D; Eisenberger U; Koch KM; Pichlmayr R; Brunkhorst R
Transplant Proc; 1998 Jun; 30(4):1251-3. PubMed ID: 9636509
[No Abstract] [Full Text] [Related]
36. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
37. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
38. FK506 rescue therapy for acute renal allograft rejection.
Goh BL; Morad Z; Cheah PL; Chua CT; Tan SY
Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
[No Abstract] [Full Text] [Related]
39. Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group.
Mentzer RM; Jahania MS; Lasley RD
Transplantation; 1998 Jan; 65(1):109-13. PubMed ID: 9448154
[TBL] [Abstract][Full Text] [Related]
40. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
